Company Deep Dive
Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.
ASCN.SW
Strong BuyFull HouseREMOVEAscom Holding AG · Healthcare · Switzerland · $222M · Avg Vol: $595K/d
While the company has shown positive insider buying and growing orders, the market capitalization is very low, creating liquidity constraints for our fund's mandate. The business model, while specialized, lacks the scale economics and 'destination' status necessary to warrant a spot in a concentrated 10-15 position book.
COMPANY DESCRIPTION
Ascom Holding AG provides mission-critical communication and collaboration solutions, primarily for the healthcare sector, including nurse call systems and mobile devices. Its specialization in highly regulated healthcare environments, offering integrated workflows and reliable communication infrastructure, forms its moat. The company is a niche global leader in healthcare communication and workflow solutions.
FINANCIAL SUMMARY (CHF)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 297.4M | 297.3M | 286.7M | 292.1M | -0.6% | 292.9M | 298.7M | 305.2M | 2.2% |
| EPS (CHF) | 0.38 | 0.31 | 0.48 | 0.10 | 0.44 | 3.9% | 0.52 | 0.45 | 0.49 | 5.4% |
| Shares | — | 35.9M | 35.9M | 35.9M | 34.2M | -4.9% | 32.9M | — | — | — |
| Debt | 0 | 10.0M | 0 | — | — | — | — | — | — | — |
| Equity | — | 73.4M | 78.7M | 74.4M | 79.9M | 2.9% | — | — | — | — |
| Op CF | — | 10.2M | 32.5M | 20.0M | 32.6M | 47.3% | 25.5M | — | — | — |
| Inv CF | — | -14.0M | -16.2M | -15.5M | -10.8M | — | — | — | — | — |
| Fin CF | — | 2.2M | -17.2M | -10.8M | -10.4M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ASCN.SW are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ASCN.SW | Ascom Holding AG(you) | $222M | 100 | Strong Buy |
| SOPH | SOPHiA GENETICS SA | $693M | 38 | Hold |
| VBSN.SW | IVF Hartmann Holding AG | $385M | 96 | Strong Buy |
| CLTN.SW | COLTENE Holding AG | $358M | 76 | Buy |
| BSLN.SW | Basilea Pharmaceutica AG | $986M | 96 | Strong Buy |
| BBZA.DE | BB Biotech AG | $3.1B | 99 | Strong Buy |
| METN.SW | Metall Zug AG | $483M | 49 | Hold |
| TECN.SW | Tecan Group AG | $3.0B | 76 | Buy |
| MOLN.SW | Molecular Partners AG | $172M | 21 | Sell |
| SANN.SW | Santhera Pharmaceuticals Holding AG | $290M | 21 | Sell |
Peer medians: ROE 10.7% · P/E 29.2x · Gross margin 62.5%